1. Home
  2. CSTE vs NSRX Comparison

CSTE vs NSRX Comparison

Compare CSTE & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$2.28

Market Cap

60.2M

Sector

Industrials

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$5.90

Market Cap

63.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSTE
NSRX
Founded
1987
2019
Country
Israel
Israel
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.2M
63.4M
IPO Year
2012
2025

Fundamental Metrics

Financial Performance
Metric
CSTE
NSRX
Price
$2.28
$5.90
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$20.50
AVG Volume (30 Days)
116.7K
6.5K
Earning Date
03-04-2026
02-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$400,656,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$5.50
52 Week High
$4.67
$9.99

Technical Indicators

Market Signals
Indicator
CSTE
NSRX
Relative Strength Index (RSI) 61.83 39.11
Support Level $2.22 $5.50
Resistance Level $2.56 $7.70
Average True Range (ATR) 0.21 0.43
MACD 0.02 -0.15
Stochastic Oscillator 65.28 15.84

Price Performance

Historical Comparison
CSTE
NSRX

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: